Luigi Mangione, the 28-year-old accused of killing a prominent health insurance executive in New York, has stepped back from a legal strategy that could have significantly altered the course of his upcoming murder trial.
A court filing submitted this week revealed that Mangione’s defense team is, at least for now, abandoning plans to present evidence suggesting he was experiencing an extreme mental health crisis when the alleged shooting occurred. The filing states that the defense is withdrawing its intention to pursue that argument “at this time,” leaving open the possibility that the issue could resurface later.
Mangione is accused of fatally shooting Brian Thompson, the chief executive of UnitedHealthcare, outside a Midtown Manhattan hotel in December 2024. The killing drew nationwide attention, not only because of Thompson’s high-profile position but also because it ignited heated public debate over healthcare costs and insurance industry practices in the United States.
The defendant has pleaded not guilty to state charges that include murder, weapons offenses and forgery. His trial is scheduled to begin in Manhattan this September.
Under New York law, defendants charged with murder may attempt to prove they acted under an “extreme emotional disturbance.” A successful argument does not result in acquittal, but it can persuade jurors to reduce a murder charge to manslaughter, dramatically lowering potential punishment and eliminating the prospect of a life sentence tied to a murder conviction.
Legal observers had questioned whether such a defense would succeed in Mangione’s case. Prosecutors have alleged that the shooting was carefully planned and that Mangione took deliberate steps to avoid capture afterward—factors that can undermine claims of overwhelming emotional disturbance.
Even if the defense had pursued the strategy, the trial judge would ultimately have decided whether enough evidence existed to allow jurors to consider reducing the charge.
The case has remained one of the most closely watched criminal prosecutions in New York. Surveillance footage of the shooting, extensive media coverage and a five-day search for the suspect kept the investigation in the public spotlight before Mangione was arrested in Pennsylvania.
Separate federal proceedings once posed an even greater threat to Mangione. He had pleaded not guilty to federal murder, weapons and stalking charges, but a judge dismissed the murder and weapons counts earlier this year on procedural grounds. That ruling removed the possibility of a death sentence.
Despite that development, Mangione still faces serious exposure in federal court. If convicted on the remaining stalking charge, he could receive a sentence of life without parole. Jury selection in the federal case is expected to begin in September, with opening arguments slated for November.
For now, the defense’s withdrawal of the emotional-disturbance argument marks a notable shift in strategy as Mangione prepares to fight the state murder case that will unfold first in a Manhattan courtroom.
